Nov [NOV] vs ChampionX [CHX] Detailed Stock Comparison
Nov
NYSE
Loading...
ChampionX
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Nov wins in 10 metrics, ChampionX wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Nov | ChampionX | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.02 | 17.09 | Nov |
| Price-to-Book Ratio | 0.70 | 2.58 | Nov |
| Debt-to-Equity Ratio | 36.15 | 34.38 | ChampionX |
| PEG Ratio | 7.78 | 13.04 | Nov |
| EV/EBITDA | 4.94 | 6.40 | Nov |
| Profit Margin (TTM) | 5.36% | 8.20% | ChampionX |
| Operating Margin (TTM) | 6.54% | 14.42% | ChampionX |
| EBITDA Margin (TTM) | 6.54% | 14.42% | ChampionX |
| Return on Equity | 7.38% | 16.83% | ChampionX |
| Return on Assets (TTM) | 4.45% | 9.44% | ChampionX |
| Free Cash Flow (TTM) | $953.00M | $448.37M | Nov |
| Dividend Yield | 1.52% | 1.90% | ChampionX |
| 1-Year Return | -35.10% | -26.45% | ChampionX |
| Price-to-Sales Ratio (TTM) | 0.51 | 1.38 | Nov |
| Enterprise Value | $5.85B | $4.87B | Nov |
| EV/Revenue Ratio | 0.67 | 1.36 | Nov |
| Gross Profit Margin (TTM) | 20.38% | 33.72% | ChampionX |
| Revenue per Share (TTM) | $23 | $19 | Nov |
| Earnings per Share (Diluted) | $1.21 | $1.51 | ChampionX |
| Beta (Stock Volatility) | 1.28 | 1.51 | Nov |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nov vs ChampionX Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nov | -3.58% | -13.17% | -6.11% | 2.10% | -15.12% | -17.48% |
| ChampionX | 0.00% | -3.04% | -2.23% | 4.54% | -11.46% | -5.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nov | -35.10% | -29.84% | 1.17% | -69.47% | -67.69% | -52.80% |
| ChampionX | -26.45% | 32.97% | 166.63% | -32.08% | -32.08% | -32.08% |
Performance & Financial Health Analysis: Nov vs ChampionX
| Metric | NOV | CHX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.50B | $4.94B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 5,074,810 | 2,539,777 |
| 90 Day Avg. Volume | 4,584,703 | 2,969,606 |
| Last Close | $12.13 | $25.81 |
| 52 Week Range | $10.84 - $20.77 | $21.92 - $35.94 |
| % from 52W High | -41.60% | -28.19% |
| All-Time High | $86.55 (Sep 01, 2014) | $46.11 (May 21, 2018) |
| % from All-Time High | -85.98% | -44.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | -0.06% |
| Quarterly Earnings Growth | -0.52% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.08% |
| Operating Margin (TTM) | 0.07% | 0.14% |
| Return on Equity (TTM) | 0.07% | 0.17% |
| Debt to Equity (MRQ) | 36.15 | 34.38 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.45 | $10.01 |
| Cash per Share (MRQ) | $2.91 | $2.75 |
| Operating Cash Flow (TTM) | $1.28B | $482.98M |
| Levered Free Cash Flow (TTM) | $821.75M | $252.59M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.52% | 1.90% |
| Last 12-Month Dividend | $0.21 | $0.50 |
Valuation & Enterprise Metrics Analysis: Nov vs ChampionX
| Metric | NOV | CHX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.02 | 17.09 |
| Forward P/E | 7.78 | 13.04 |
| PEG Ratio | 7.78 | 13.04 |
| Price to Sales (TTM) | 0.51 | 1.38 |
| Price to Book (MRQ) | 0.70 | 2.58 |
| Market Capitalization | ||
| Market Capitalization | $4.50B | $4.94B |
| Enterprise Value | $5.85B | $4.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | 1.36 |
| Enterprise to EBITDA | 4.94 | 6.40 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.51 |
| Book Value per Share (MRQ) | $17.45 | $10.01 |
Financial Statements Comparison: Nov vs ChampionX
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NOV | CHX |
|---|---|---|
| Revenue/Sales | $2.10B | $864.46M |
| Cost of Goods Sold | $1.66B | $572.94M |
| Gross Profit | $447.00M | $291.53M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $152.00M | $114.48M |
| EBITDA | $232.00M | $179.17M |
| Pre-Tax Income | $121.00M | $104.41M |
| Income Tax | $47.00M | $15.38M |
| Net Income (Profit) | $74.00M | $89.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NOV | CHX |
|---|---|---|
| Cash & Equivalents | $1.16B | $526.56M |
| Total Current Assets | $5.78B | $1.77B |
| Total Current Liabilities | $2.18B | $784.90M |
| Long-Term Debt | $2.23B | $633.17M |
| Total Shareholders Equity | $6.49B | $1.90B |
| Retained Earnings | $-583.00M | $-171.24M |
| Property, Plant & Equipment | $2.49B | $1.54B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NOV | CHX |
|---|---|---|
| Operating Cash Flow | $280.00M | $63.44M |
| Capital Expenditures | $-84.00M | $3.00M |
| Free Cash Flow | $51.00M | $35.55M |
| Debt Repayment | $-4.00M | $-5.38M |
| Common Stock Repurchase | $-81.00M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | NOV | CHX |
|---|---|---|
| Shares Short | 29.95M | 4.50M |
| Short Ratio | 6.57 | 1.56 |
| Short % of Float | 0.17% | 0.03% |
| Average Daily Volume (10 Day) | 5,074,810 | 2,539,777 |
| Average Daily Volume (90 Day) | 4,584,703 | 2,969,606 |
| Shares Outstanding | 381.55M | 190.70M |
| Float Shares | 368.04M | 189.36M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.07% | 0.96% |
Dividend Analysis & Yield Comparison: Nov vs ChampionX
| Metric | NOV | CHX |
|---|---|---|
| Last 12-Month Dividend | $0.21 | $0.50 |
| Last 12-Month Dividend Yield | 1.52% | 1.90% |
| 3-Year Avg Annual Dividend | $0.21 | $0.39 |
| 3-Year Avg Dividend Yield | 0.35% | 0.31% |
| 3-Year Total Dividends | $0.63 | $1.17 |
| Ex-Dividend Date | Mar 14, 2025 | Jul 03, 2025 |